Lyra Therapeutics (LYRA) FCF Margin (QoQ) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Lyra Therapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.86 Mn |
| Sep 30, 2025 | -2.58 Mn |
| Jun 30, 2025 | 123,060.00 |
| Mar 31, 2025 | 57,213.00 |
| Dec 31, 2024 | 411,156.00 |
| Sep 30, 2024 | -622,191.00 |
| Jun 30, 2024 | 99,318.00 |
| Mar 31, 2024 | 918,800.00 |
| Dec 31, 2023 | -1.09 Mn |
| Sep 30, 2023 | 55,921.00 |
| Jun 30, 2023 | 74,299.00 |
| Mar 31, 2023 | 10.70 Mn |
| Dec 31, 2022 | -10.78 Mn |
| Sep 30, 2022 | -146,062.00 |
| Jun 30, 2022 | 96,691.00 |
| Mar 31, 2022 | 246,695.00 |
| Dec 31, 2021 | 6.34 Mn |